According to @CNBC, 2026 will bring more GLP-1 weight loss pills and new consumer habits, and it identifies stocks poised to benefit in its report (Source: @CNBC). For trading, the source signals a 2026 theme centered on GLP-1 pill expansion and names equities to watch, directing investors to its coverage for the specific companies referenced (Source: @CNBC). The source did not mention any direct cryptocurrency market impact (Source: @CNBC).